臺灣博碩士論文加值系統

我們利用DNA鬆懈實驗、DPPH清除能力及電子自旋共振法的技術去研究八種香豆素及其衍生物在抗氧化活性、自由基捕捉能力的表現。此外，我們去評估這些香豆素及其衍生物對於黃嘌呤氧化酶活性的抑制能力，且進一步利用分子模擬技術去解釋這些衍生物對於黃嘌呤氧化酶活性的抑制結構-活性關係。我們發現esculetin 和 4-methylesculetin具有最佳的自由基清除能力，推測其結構中的取代的官能基種類和氫氧基團數目與自由基清除能力有關。結果發現所有的香豆素衍生物都具有抑制黃嘌呤氧化酶活性的能力，且其抑制型態屬於競爭型抑制劑。由此可確認在以分子模擬時可與黃嘌呤氧化酶活性中心對位。由分子模擬的結果，可以發現香豆素衍生物的α-pyrone環結構可與黃嘌呤氧化酶受質結合位入口的苯丙胺酸（Phe）914具π-π重疊力，而O-1和C-2羰基上的氧原子可與黃嘌呤氧化酶的精胺酸（Arg）880或透過水分子與精胺酸（Arg）880的NH基團、酥胺酸（Thr）1010的OH基團形成氫鍵。在8種香豆素衍生物中發現esculetin與黃嘌呤氧化酶的親和力最高，因為在esculetin的結構上，C-6的OH基團可與麩胺酸（Glu）802的COOH基團形成氫鍵，此鍵結對於抑制黃嘌伶氧化酶活性是很重要的，因而增加了兩者結合的穩定性。最後以電子自旋共振法，利用 Hypoxanthine/ Xanthine Oxidase反應體系，產生之•O2-自由基，去評估香豆素及其衍生物對於黃嘌呤氧化酶活性抑制和自由基清除的能力的整體表現，結果顯示esculetin 和 4-methylesculetin具有最佳的活性。由於Aβ肽造成神經細胞傷害涉及自由基的過度生成，因此我們將上述結構-活性關係結論進一步應用在活體細胞實驗的表現，結果顯示esculetin可以透過抑制自由基生成或自由基清除作用而降低Aβ所引發的細胞毒性。

We employed the techniques of DNA relaxation, DPPH, and DMPO-electron spin resonance (ESR), to study the effects of the reactive oxygen species (ROS) suppression by 8 selected coumarin and derivatives under oxidative conditions. We also investigated the effect of these derivatives on the inhibition of xanthine oxidase (XO) activity, and the structure-activity relationships (SARs) of these derivatives against XO activity were further examined using computer and molecular modeling. Esculetin and 4-methylesculetin express the more potent radical scavenger among the 8 test compounds. Our results suggest that the chemical structure and number of hydroxyl groups on the benzene ring of coumarin were correlated with the effects of ROS suppression. All test derivatives were competitive inhibitors of XO. The results of the structure-based molecular modeling exhibited interactions between coumarin derivatives and the molybdopterin region of XO. The α-pyrone ring of coumarin derivatives stacked with the phenyl at Phe 914. Two hydrogen bonding interactions were observed involving the O-1 of the coumarin derivatives with the guanidinium group of Arg 880, carbonyl group of coumarin derivatives with Thr 1010. Esculetin had the highest affinity toward the binding site of XO, and this was due to hydrogen bonding interactions. The hydroxyl group at C-6 formed hydrogen bonds with the carboxyl group Glu802 that played critical role on XO binding. The hypoxanthine/XO reaction in the DMPO-ESR technique was used to correlate the effect on enzyme inhibition and ROS suppression by these coumarin derivatives, and the results showed that esculetin and 4-methylesculetin were the two most potent agents among the tested compounds. Aβ（β-amyloid peptide） induce neuronal cell damage by increasing the generation of ROS. Therefore, we further assessed the effects of test compounds on living cells. Esculetin was the most potent agent at protecting cells against Aβ induced cell cytotoxisity via inhibiting the generation of ROS or ROS scavenging among the tested coumarin derivatives.

目錄…………………………………………………………Ⅰ
中文摘要……………………………………………………Ⅱ
英文摘要……………………………………………………Ⅲ
圖目錄………………………………………………………Ⅴ
表目錄………………………………………………………Ⅵ
緒論………………………………………………………… 1
實驗材料與方法……………………………………………10
結果…………………………………………………………21
討論…………………………………………………………28
圖表…………………………………………………………34
參考文獻……………………………………………………53
附錄…………………………………………………………60

Bashir, S., S.M. Shah, and I. Babar. 2000. Allopurinol induced Stevens-Johnson syndrome: a case report. J Pak Med Assoc. 50:207-9.
Buettner, G.R. 1987. Spin trapping: ESR parameters of spin adducts. Free Radic Biol Med. 3:259-303.
Chang, W.S., Y.H. Chang, F.J. Lu, and H.C. Chiang. 1994. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 14:501-6.
Chang, W.S., and H.C. Chiang. 1995. Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res. 15:1969-73.
Chang, W.S., C.C. Lin, S.C. Chuang, and H.C. Chiang. 1996. Superoxide anion scavenging effect of coumarins. Am J Chin Med. 24:11-7.
Chen, I.H., M.C. Kuo, S.J. Hwang, J.M. Chang, and H.C. Chen. 2005. Allopurinol-induced severe hypersensitivity with acute renal failure. Kaohsiung J Med Sci. 21:228-32.
Chu, C.Y., Y.Y. Tsai, C.J. Wang, W.L. Lin, and T.H. Tseng. 2001. Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol. 416:25-32.
Chun, K.S., S.H. Kim, Y.S. Song, and Y.J. Surh. 2004. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis. 25:713-22.
de Mello, S.B., G.S. Novaes, I.M. Laurindo, M.N. Muscara, F.M. Maciel, and W. Cossermelli. 1997. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints. Inflamm Res. 46:72-7.
Ding, Z., Y. Dai, and Z. Wang. 2005. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity. Planta Med. 71:183-5.
Egan, D., R. O''Kennedy, E. Moran, D. Cox, E. Prosser, and R.D. Thornes. 1990. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. 22:503-29.
Enroth, C., B.T. Eger, K. Okamoto, T. Nishino, T. Nishino, and E.F. Pai. 2000. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A. 97:10723-8.
Fitzpatrick, F.A. 2001. Inflammation, carcinogenesis and cancer. Int Immunopharmacol. 1:1651-67.
Fukunari, A., K. Okamoto, T. Nishino, B.T. Eger, E.F. Pai, M. Kamezawa, I. Yamada, and N. Kato. 2004. Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy) phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J Pharmacol Exp Ther. 311:519-28.
Fylaktakidou, K.C., D.J. Hadjipavlou-Litina, K.E. Litinas, and D.N. Nicolaides. 2004. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr Pharm Des. 10:3813-33.
Gao, X., and X.C. Tang. 2006. Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J Neurosci Res. 83:1048-57.
Gottsch, J.D., S. Pou, L.A. Bynoe, and G.M. Rosen. 1990. Hematogenous photosensitization. A mechanism for the development of age-related macular degeneration. Invest Ophthalmol Vis Sci. 31:1674-82.
Gupta, A., S.F. Rosenberger, and G.T. Bowden. 1999. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis. 20:2063-73.
Hajime, M., Y. Shuichi, N. Makoto, Y. Masanori, K. Ikuko, K. Atsushi, S. Mutsuo, and T. Keiichi. 2007. Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice. Int J Cancer. 120:2704-9.
Ibarreta, D., R. Parrilla, and M.S. Ayuso. 1997. Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 11:220-7.
Kadowaki, H., H. Nishitoh, F. Urano, C. Sadamitsu, A. Matsuzawa, K. Takeda, H. Masutani, J. Yodoi, Y. Urano, T. Nagano, and H. Ichijo. 2005. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 12:19-24.
Kaneko, T., S. Tahara, and F. Takabayashi. 2003. Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biol Pharm Bull. 26:840-4.
Keller, J.N., Q. Guo, F.W. Holtsberg, A.J. Bruce-Keller, and M.P. Mattson. 1998. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci. 18:4439-50.
Khan, N., S. Sharma, and S. Sultana. 2004. Amelioration of ferric nitrilotriacetate (Fe-NTA) induced renal oxidative stress and tumor promotion response by coumarin (1,2-benzopyrone) in Wistar rats. Cancer Lett. 210:17-26.
Kim, E.K., K.B. Kwon, B.C. Shin, E.A. Seo, Y.R. Lee, J.S. Kim, J.W. Park, B.H. Park, and D.G. Ryu. 2005. Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor kappaB and caspase-3. Life Sci. 77:824-36.
Kim, H.J., S.I. Jang, Y.J. Kim, H.T. Chung, Y.G. Yun, T.H. Kang, O.S. Jeong, and Y.C. Kim. 2004. Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia. 75:261-6.
Kong, L.D., Y. Zhang, X. Pan, R.X. Tan, and C.H. Cheng. 2000. Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Cell Mol Life Sci. 57:500-5.
Kontogiorgis, C.A., and D.J. Hadjipavlou-Litina. 2005. Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem. 48:6400-8.
Kuo, H.C., H.J. Lee, C.C. Hu, H.I. Shun, and T.H. Tseng. 2006. Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol Appl Pharmacol. 210:55-62.
Lala, P.K., and C. Chakraborty. 2001. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2:149-56.
Lee, S.Y., J.W. Lee, H. Lee, H.S. Yoo, Y.P. Yun, K.W. Oh, T.Y. Ha, and J.T. Hong. 2005. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res Mol Brain Res. 140:45-54.
Lin, C.M., C.S. Chen, C.T. Chen, Y.C. Liang, and J.K. Lin. 2002. Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun. 294:167-72.
Lin, M.S., Y.S. Dai, R.F. Pwu, Y.H. Chen, and N.C. Chang. 2005. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J. 35:188-90.
Lin, W.L., C.J. Wang, Y.Y. Tsai, C.L. Liu, J.M. Hwang, and T.H. Tseng. 2000. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 74:467-72.
Lukiw, W.J., and N.G. Bazan. 2000. Neuroinflammatory signaling upregulation in Alzheimer''s disease. Neurochem Res. 25:1173-84.
Martin-Aragon, S., J.M. Benedi, and A.M. Villar. 1998. Effects of the antioxidant (6,7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology. 44:21-5.
Moon, P.D., B.H. Lee, H.J. Jeong, H.J. An, S.J. Park, H.R. Kim, S.G. Ko, J.Y. Um, S.H. Hong, and H.M. Kim. 2007. Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IkappaB/NF-kappaB signal cascade in the human mast cell line HMC-1. Eur J Pharmacol. 555:218-25.
Mukherjee, T.K., S. Mukhopadhyay, and J.R. Hoidal. 2005. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta. 1744:213-23.
Muschietti, L., S. Gorzalczany, G. Ferraro, C. Acevedo, and V. Martino. 2001. Phenolic compounds with anti-inflammatory activity from Eupatorium buniifolium. Planta Med. 67:743-4.
Niskanen, L.K., D.E. Laaksonen, K. Nyyssonen, G. Alfthan, H.M. Lakka, T.A. Lakka, and J.T. Salonen. 2004. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 164:1546-51.
Oh, S.H., and S.C. Lim. 2006. A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation. Toxicol Appl Pharmacol. 212:212-23.
Ohshima, H., M. Tatemichi, and T. Sawa. 2003. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys. 417:3-11.
Okamoto, K., B.T. Eger, T. Nishino, S. Kondo, E.F. Pai, and T. Nishino. 2003. An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J Biol Chem. 278:1848-55.
Okamoto, K., K. Matsumoto, R. Hille, B.T. Eger, E.F. Pai, and T. Nishino. 2004. The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci U S A. 101:7931-6.
Pavlick, K.P., F.S. Laroux, J. Fuseler, R.E. Wolf, L. Gray, J. Hoffman, and M.B. Grisham. 2002. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 33:311-22.
Paya, M., B. Halliwell, and J.R. Hoult. 1992. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol. 44:205-14.
Pryor, W.A., K. Terauchi, and W.H. Davis, Jr. 1976. Electron spin resonance (ESR) study of cigarette smoke by use of spin trapping techniques. Environ Health Perspect. 16:161-76.
Salkowski, C.A., G. Detore, R. McNally, N. van Rooijen, and S.N. Vogel. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol. 158:905-12.
Sanchez-Lozada, L.G., E. Tapia, C. Avila-Casado, V. Soto, M. Franco, J. Santamaria, T. Nakagawa, B. Rodriguez-Iturbe, R.J. Johnson, and J. Herrera-Acosta. 2002. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol. 283:F1105-10.
Sharma, S.D., H.K. Rajor, S. Chopra, and R.K. Sharma. 2005. Studies on structure activity relationship of some dihydroxy-4-methylcoumarin antioxidants based on their interaction with Fe(III) and ADP. Biometals. 18:143-54.
Shaw, C.Y., C.H. Chen, C.C. Hsu, C.C. Chen, and Y.C. Tsai. 2003. Antioxidant properties of scopoletin isolated from Sinomonium acutum. Phytother Res. 17:823-5.
Silvan, A.M., M.J. Abad, P. Bermejo, M. Sollhuber, and A. Villar. 1996. Antiinflammatory activity of coumarins from Santolina oblongifolia. J Nat Prod. 59:1183-5.
Szasz, T., K. Thakali, G.D. Fink, and S.W. Watts. 2007. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood). 232:27-37.
Takeshita, K., and T. Ozawa. 2004. Recent progress in in vivo ESR spectroscopy. J Radiat Res (Tokyo). 45:373-84.
Utsumi, H., and K. Yamada. 2003. In vivo electron spin resonance-computed tomography/nitroxyl probe technique for non-invasive analysis of oxidative injuries. Arch Biochem Biophys. 416:1-8.
Wallace, S.L., H. Robinson, A.T. Masi, J.L. Decker, D.J. McCarty, and T.F. Yu. 1977. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 20:895-900.
Wang, C.J., Y.J. Hsieh, C.Y. Chu, Y.L. Lin, and T.H. Tseng. 2002. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 183:163-8.
Weber, U.S., B. Steffen, and C.P. Siegers. 1998. Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Res Commun Mol Pathol Pharmacol. 99:193-206.
Xie, Z., M. Singh, and K. Singh. 2004. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol. 198:399-407.
Yang, J.Y., M.A. Della-Fera, and C.A. Baile. 2006a. Esculetin induces mitochondria-mediated apoptosis in 3T3-L1 adipocytes. Apoptosis. 11:1371-8.
Yang, J.Y., M.A. Della-Fera, D.L. Hartzell, C. Nelson-Dooley, D.B. Hausman, and C.A. Baile. 2006b. Esculetin induces apoptosis and inhibits adipogenesis in 3T3-L1 cells. Obesity (Silver Spring). 14:1691-9.
Zhao, H., N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, G.W. Milne, Y. Pommier, and T.R. Burke, Jr. 1997. Coumarin-based inhibitors of HIV integrase. J Med Chem. 40:242-9.
Zhu, Y., P. Hoell, B. Ahlemeyer, U. Sure, H. Bertalanffy, and J. Krieglstein. 2007. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson''s disease. Neurochem Int. 50:507-16.